(Q38253205)

English

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

scientific article published on 23 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Siamak Daneshmand

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Bernard H Bochner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Anne K Schuckman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Michael S Cookson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Tracy M Downs

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Leonard G Gomella

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

H Barton Grossman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ashish M Kamat

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Badrinath R Konety

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Cheryl T Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kamal S Pohar

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Raj S Pruthi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Matthew J Resnick

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Norm D Smith

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Alfred Witjes

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mark P Schoenberg

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Gary D Steinberg

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

23 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nature Reviews Urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

589-596

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The costs of non-muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Hexyl aminolevulinate: in the detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

21 January 2018

Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

The value of a second transurethral resection for T1 bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Results of second-look resection after primary resection of T1 tumour of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.245

31 March 2020

A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25245244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NRUROL.2014.245

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25245244%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38253205&oldid=2201472076"